BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2930626)

  • 21. Quinazoline antifolate thymidylate synthase inhibitors: bridge modifications and conformationally restricted analogues in the C2-methyl series.
    Marsham PR; Jackman AL; Hayter AJ; Daw MR; Snowden JL; O'Connor BM; Bishop JA; Calvert AH; Hughes LR
    J Med Chem; 1991 Jul; 34(7):2209-18. PubMed ID: 2066994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
    Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folate analogues. 35. Synthesis and biological evaluation of 1-deaza, 3-deaza, and bridge-elongated analogues of N10-propargyl-5,8-dideazafolic acid.
    Li SW; Nair MG; Edwards DM; Kisliuk RL; Gaumont Y; Dev IK; Duch DS; Humphreys J; Smith GK; Ferone R
    J Med Chem; 1991 Sep; 34(9):2746-54. PubMed ID: 1895294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the biological effects of selected 5,8-dideazafolate analogues with their 2-desamino counterparts.
    Hynes JB; Patil SA; Hagan RL; Cole A; Kohler W; Freisheim JH
    J Med Chem; 1989 Apr; 32(4):852-6. PubMed ID: 2704031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quinazoline-based thymidylate synthase inhibitors: relationship between structural modifications and polyglutamation.
    Jackman AL; Kimbell R; Brown M; Brunton L; Bisset GM; Bavetsias V; Marsham P; Hughes LR; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):573-89. PubMed ID: 7495480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quinazoline antifolate thymidylate synthase inhibitors: alkyl, substituted alkyl, and aryl substituents in the C2 position.
    Hughes LR; Jackman AL; Oldfield J; Smith RC; Burrows KD; Marsham PR; Bishop JA; Jones TR; O'Connor BM; Calvert AH
    J Med Chem; 1990 Nov; 33(11):3060-7. PubMed ID: 2231606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinoline antifolate thymidylate synthase inhibitors: variation of the C2- and C4-substituents.
    Warner P; Barker AJ; Jackman AL; Burrows KD; Roberts N; Bishop JA; O'Connor BM; Hughes LR
    J Med Chem; 1992 Jul; 35(15):2761-8. PubMed ID: 1495009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
    Bavetsias V; Marriott JH; Melin C; Kimbell R; Matusiak ZS; Boyle FT; Jackman AL
    J Med Chem; 2000 May; 43(10):1910-26. PubMed ID: 10821704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quinazoline antifolate thymidylate synthase inhibitors: heterocyclic benzoyl ring modifications.
    Marsham PR; Hughes LR; Jackman AL; Hayter AJ; Oldfield J; Wardleworth JM; Bishop JA; O'Connor BM; Calvert AH
    J Med Chem; 1991 May; 34(5):1594-605. PubMed ID: 2033585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Syntheses and thymidylate synthase inhibitory activity of the poly-gamma-glutamyl conjugates of N-[5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino ]-2-thenoyl]-L-glutamic acid (ICI D1694) and other quinazoline antifolates.
    Bisset GM; Pawelczak K; Jackman AL; Calvert AH; Hughes LR
    J Med Chem; 1992 Mar; 35(5):859-66. PubMed ID: 1372358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sulfamide antifolates inhibiting thymidylate synthase: synthesis, enzyme inhibition and cytotoxicity.
    Pawełczak K; Makowski M; Kempny M; Dzik JM; Gołos B; Rode W; Rzeszotarska B
    Acta Biochim Pol; 2002; 49(2):407-20. PubMed ID: 12362982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The biochemical pharmacology of the thymidylate synthase inhibitor, 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Jackman AL; Newell DR; Gibson W; Jodrell DI; Taylor GA; Bishop JA; Hughes LR; Calvert AH
    Biochem Pharmacol; 1991 Oct; 42(10):1885-95. PubMed ID: 1741766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinazoline antifolate thymidylate synthase inhibitors: benzoyl ring modifications in the C2-methyl series.
    Marsham PR; Jackman AL; Oldfield J; Hughes LR; Thornton TJ; Bisset GM; O'Connor BM; Bishop JA; Calvert AH
    J Med Chem; 1990 Nov; 33(11):3072-8. PubMed ID: 2231608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quinazoline antifolates inhibiting thymidylate synthase: synthesis of four oligo(L-gamma-glutamyl) conjugates of N10-propargyl-5,8-dideazafolic acid and their enzyme inhibition.
    Pawelczak K; Jones TR; Kempny M; Jackman AL; Newell DR; Krzyzanowski L; Rzeszotarska B
    J Med Chem; 1989 Jan; 32(1):160-5. PubMed ID: 2909728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
    Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quinazoline antifolate thymidylate synthase inhibitors: replacement of glutamic acid in the C2-methyl series.
    Marsham PR; Jackman AL; Barker AJ; Boyle FT; Pegg SJ; Wardleworth JM; Kimbell R; O'Connor BM; Calvert AH; Hughes LR
    J Med Chem; 1995 Mar; 38(6):994-1004. PubMed ID: 7699716
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent preclinical and clinical studies with the thymidylate synthase inhibitor N10-propargyl-5,8-dideazafolic acid (CB 3717).
    Calvert AH; Newell DR; Jackman AL; Gumbrell LA; Sikora E; Grzelakowska-Sztabert B; Bishop JA; Judson IR; Harland SJ; Harrap KR
    NCI Monogr; 1987; (5):213-8. PubMed ID: 3431591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Folate analogues. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds.
    Patil SD; Jones C; Nair MG; Galivan J; Maley F; Kisliuk RL; Gaumont Y; Duch D; Ferone R
    J Med Chem; 1989 Jun; 32(6):1284-9. PubMed ID: 2542557
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.